Loading clinical trials...
Loading clinical trials...
An Open-label Study to Evaluate the Pharmacokinetics and Safety of BAY 1817080 in Participants With Impaired Renal Function in Comparison to Matched Controls With Normal Renal Function
Conditions
Interventions
BAY1817080
Locations
2
United States
Clinical Pharmacology of Miami, LLC
Miami, Florida, United States
Orlando Clinical Research Center
Orlando, Florida, United States
Start Date
August 12, 2020
Primary Completion Date
February 15, 2021
Completion Date
May 6, 2021
Last Updated
March 26, 2024
NCT05986292
NCT06789406
NCT05362292
NCT07193407
NCT07195656
NCT07209397
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions